Status:
COMPLETED
Home Airway Clearance in Patients With Bronchiectasis (Home-Care Bronchiectasis)
Lead Sponsor:
Physio-Assist
Collaborating Sponsors:
Icadom
Conditions:
Bronchiectasis Adult
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bronchiectasis is a chronic multiple etiologies pulmonary disease characterized by permanent dilatation of the caliber of the bronchial tree territory with an alteration of mucociliary clearance. This...
Detailed Description
Bronchiectasis is a chronic multiple etiologies pulmonary disease characterized by permanent and abnormal dilatation of the caliber of a territory of the bronchial tree with an alteration of mucocilia...
Eligibility Criteria
Inclusion
- Patient with a diagnosis of bronchiectasis confirmed by HR CT scan, regardless of etiology except cystic fibrosis and with estimated bronchorrhea \>10mL/d.
- Disease stability, defined as a delay of at least 4 weeks since the end of an exacerbation (end of antibiotic therapy or judged as resolved by the investigator).
- Age \> 18 years old
- Patient does not have access to a physiotherapist or does not usually go to a physiotherapy office (\<1/week on average)
Exclusion
- Pneumothorax or severe hemoptysis (more than 30 ml per 24 hours) within 6 weeks before inclusion,
- Patient on transplant list
- Any contraindication to an instrumental bronchial clearance technique (at the discretion of the investigator)
- Patient not available or wishing to change of region within 3 months of inclusion
- Patient is currently participating or has participated within one month prior to inclusion in another clinical intervention research study that may impact the study, the impact of which is at the discretion of the investigator.
- Persons referred to in articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: pregnant woman (verified by the dosage of β-HCG for any woman wishing to participate in the protocol and of childbearing age \< 60 years), parturient, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure)
Key Trial Info
Start Date :
March 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04742270
Start Date
March 4 2021
End Date
December 31 2021
Last Update
January 4 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Grenoble University-Affiliated Hospital : Pneumology department
Grenoble, France, 38043
2
Nice university-affiliated hospital : pneumonoly department
Nice, France, 06001
3
Toulouse University-Affiliated Hospital : Pneumology department
Toulouse, France, 31030